Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Jun;14(2):255-264.
doi: 10.1007/s44197-024-00203-x. Epub 2024 Feb 26.

The Effect of COVID-19 on Male Sex Hormones: A Meta-Analysis of Prospective Cohort Study

Affiliations
Review

The Effect of COVID-19 on Male Sex Hormones: A Meta-Analysis of Prospective Cohort Study

Xiucheng Lan et al. J Epidemiol Glob Health. 2024 Jun.

Abstract

Purpose: To evaluate the possible effects of novel coronavirus disease 2019 (2019-NCOV) on male sex hormones and reproductive ability, and analyze its incidence and risk factors.

Methods: We retrieved from PubMed, Embase, The Cochrane Library, Web of Science, Clinical Trails, CNKI, CBM, Wan Fang Database and VIP to collect research on the effects of COVID-19 on the male sex hormone. Our literature search was conducted until April 2022, and two investigators independently screened articles based on inclusion and exclusion criteria. In strict accordance with the inclusion and exclusion criteria, two researchers independently screened the literature and comprehensively analyzed 8 cohort studies on the impact of COVID-19 on male sex hormone. And We used RevMan5.4.1 and Stata15.0 for statistical analysis. Finally, there were eight cohort studies on the effects of COVID-19 on male sex hormones.

Results: T(RR = - 3.94; 95% CI - 6.22, - 1.66; P = 0.0007), testosterone in the COVID-19 group decreased by 3.94 nmol/L compared with the control group, and the difference was statistically significant. LH (RR = 0.85; 95% CI - 0.26, 1.96; P = 0.13), the LH in COVID-19 group was 0.85 mlU/ml higher than that in control group, but the difference was not statistically significant. FSH (RR = 0.25; 95% CI - 0.72, 1.23; P = 0.61), the FSH of COVID-19 group was 0.25 mlU/ml higher than that of the control group, but the difference was not statistically significant. PRL (RR = 2.42; 95% CI 0.52, 4.31; P = 0.01), the PRL in the COVID-19 group was 2.42 ng/ml higher than that in the control group, and the difference was statistically significant. E2(RR = 11.88; 95% CI 9.90, 13.86; P < 0.00001), The level of E2 in the COVID-19 group was 11.88 pg/ml higher than that in the control group, and the difference was statistically significant. T:LH (RR = - 0.39; 95% CI - 076, - 0.02; P = 0.04), the ratio of T:LH in COVID-19 group was lower than that in control group, and the difference was statistically significant. FSH:LH (RR = - 0.38; 95% CI - 0.86, 0.11; P = 0.13), the ratio of FSH:LH decreased in COVID-19 group compared with control group, but the difference was not statistically significant.

Conclusions: COVID-19 can affect the level of sex hormones, especially T, which may further affect male fertility. Due to the limitations of this study, this conclusion needs to be further verified by large-sample, high-quality prospective cohort studies on the long-term effects of COVID-19 on male sex hormones and fertility.

Keywords: COVID-19; Luteinizing hormone; Male fertility; Sex hormone; Testosterone.

PubMed Disclaimer

Conflict of interest statement

The authors have no competing interests to declare that are relevant to the content of this article.

Figures

Fig. 1
Fig. 1
Summary of the literature identification and selection process. ∗ signifies PubMed = 87, Cochrane library = 27, Embase = 1054, Web of science = 506, CBM = 6, CNKI = 4, Wanfang = 22, VIP = 10
Fig. 2
Fig. 2
Forest plot of sex hormones between COVID-19 group and healthy control group
Fig. 3
Fig. 3
Forest plot of sex hormone subgroup analysis between COVID-19 group and healthy control group
Fig. 4
Fig. 4
Funnel plot of sex hormones between COVID-19 group and healthy control group
Fig. 5
Fig. 5
Egger’s test of sex hormones between COVID-19 group and healthy control group

Similar articles

References

    1. Sun Bang Wu, Xueyan NM. Damage and mechanism of novel coronavirus to male reproduction. Chin J Androl. 2021;27(08):738–741. doi: 10.13263/j.cnki.nja.2021.08.012. - DOI
    1. Apaydin T, Sahin B, Dashdamirova S, Dincer Yazan C, Elbasan O, Ilgin C, et al. The association of free testosterone levels with coronavirus disease 2019. Andrology. 2022 doi: 10.1111/andr.13152. - DOI - PubMed
    1. Xu W, Lixiang Z, Liya A, Yingenzyme Z, Huan-Rui S, Ruo-peng Z. Effects of novel coronavirus disease 2019 (2019-NCOV) on reproductive systems of both sexes. Chin J Eugenics Genetics. 2021;29(06):884–7. doi: 10.13404/j.cnki.cjbhh.20210927.019. - DOI
    1. Cinislioglu AE, Cinislioglu N, Demirdogen SO, Sam E, Akkas F, Altay MS, et al. The relationship of serum testosterone levels with the clinical course and prognosis of COVID-19 disease in male patients: a prospective study. Andrology. 2022;10(1):24–33. doi: 10.1111/andr.13081. - DOI - PMC - PubMed
    1. Enikeev D, Taratkin M, Morozov A, Petov V, Korolev D, Shpikina A, et al. Prospective two-arm study of the testicular function in patients with COVID-19. Andrology. 2022 doi: 10.1111/andr.13159. - DOI - PMC - PubMed